Nutrition in Clinical Care
Potential treatment of human nonalcoholic fatty liver disease with long-chain omega-3 polyunsaturated fatty acids
Version of Record online: 22 OCT 2013
© 2013 International Life Sciences Institute
Volume 71, Issue 11, pages 753–771, November 2013
How to Cite
Bouzianas, D. G., Bouziana, S. D. and Hatzitolios, A. I. (2013), Potential treatment of human nonalcoholic fatty liver disease with long-chain omega-3 polyunsaturated fatty acids. Nutrition Reviews, 71: 753–771. doi: 10.1111/nure.12073
- Issue online: 11 NOV 2013
- Version of Record online: 22 OCT 2013
Table S1 Effects of n-3 PUFA supplementation in animal models of NAFLD/NASH.
Table S2 Summary of design, methodology, and results of clinical trials investigating n-3 PUFA supplementation in humans with NAFLD/NASH (2004–2011).
Table S3 Ongoing clinical trials of n-3 PUFA supplementation in NAFLD/NASH patients.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.